TRVI - Trevi Therapeutics' (TRVI) CEO Jennifer Good on Q3 2020 Results - Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Jennifer Good – President and Chief Executive Officer Chris Seiter – Chief Financial Officer Conference Call Participants Gary Nachman – BMO Capital Markets Ami Fadia – Leerink Serge Belanger – Needham & Company Annabel Samimy – Stifel Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call may be recorded. Various remarks that management makes during this call about the company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking

For further details see:

Trevi Therapeutics' (TRVI) CEO Jennifer Good on Q3 2020 Results - Earnings Call Transcript